Health
London: Oxford University’s AstraZeneca vaccine candidate, AZD1222, which is being developed against COVID-19 disease has shown 70 percent efficiency on average, officials said. more
Oxford Vaccine trials resume in UK days after pause over volunteer's illness
London: Pharmaceutical giant AstraZeneca on Saturday resumed the trials of Covid-19 vaccine in the United Kingdom after a brief halt following a volunteer's illness, media reports sai ...
Oxford University's COVID-19 vaccine triggers 'strong immune response'
London: Setting a big mark of progress, a coronavirus vaccine developed by the University of Oxford has produced a strong immune response and appeared to be safe, a new study revealed on ...
